Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDIA6 | Q15084 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 9/20 | 0.36 |
| ▸ | CA1 | P00915 | 8/20 | 0.36 |
| ▸ | CA9 | Q16790 | 8/20 | 0.36 |
| ▸ | CA12 | O43570 | 7/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 3/20 | 0.35 |
| ▸ | CA5A | P35218 | 2/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.35 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | BRD2 | P25440 | 1/20 | 0.35 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butane SCHEMBL20214161 | 0.97 | PDIA6 (0.37) | PDIA6ALDH1A1CA2CA1CA9 | |
| SCHEMBL29169847 | 0.79 | CA1 (0.36) | CA2CA1CA9CA12CA14 | |
| SCHEMBL7705793 | 0.76 | PDIA6 (0.42) | PDIA6ALDH1A1CA2CA1CA9 | |
| SCHEMBL9253769 | 0.74 | GABRA1 (0.41) | CA2CA1CA9CA12CA14 | |
| SCHEMBL5412420 | 0.73 | MEN1 (0.34) | ALDH1A1GAAL3MBTL1POLBKDM4E | |
| SCHEMBL2059594 | 0.73 | POLB (0.33) | POLBFFAR4 | |
| SCHEMBL30114992 | 0.73 | SRD5A1 (0.45) | ALDH1A1GAAL3MBTL1POLBKDM4E | |
| SCHEMBL4976094 | 0.73 | IMPDH2 (0.45) | ALDH1A1POLBNPSR1 | |
| SCHEMBL5849188 | 0.73 | SRD5A1 (0.45) | ALDH1A1GAAL3MBTL1POLBKDM4E | |
| SCHEMBL4621379 | 0.73 | PDIA6 (0.40) | PDIA6ALDH1A1CA2CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3548501-B1 | NOVEL RUTHENIUM COMPLEX, METHOD OF ITS PRODUCTION AND ITS USE IN REACTION OF OLEFINE METATHESIS | UNIV WARSZAWSKI (PL) | 2021-02-17 | — | — | EP | disclosed |
| EP-3548501-A1 | NOVEL RUTHENIUM COMPLEX, METHOD OF ITS PRODUCTION AND ITS USE IN REACTION OF OLEFINE METATHESIS | Uniwersytet Warszawski (PL) | 2019-10-09 | — | — | EP | disclosed |
| WO-2018100515-A1 | NOVEL RUTHENIUM COMPLEX, METHOD OF ITS PRODUCTION AND ITS USE IN REACTION OF OLEFINE METATHESIS | UNIWERSYTET WARSZAWSKI (PL) | 2018-06-07 | — | — | WO | disclosed |
| US-20180065914-A1 | RUTHENIUM POLYMERISATION CATALYSTS | UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2018-03-08 | — | — | US | disclosed |
| US-9815765-B2 | Ruthenium polymerisation catalysts | UNIVERSITY COURT OF THE UNIVERSITY OF ST. ANDREWS (GB) | 2017-11-14 | — | — | US | disclosed |
| EP-3055063-A1 | RUTHENIUM POLYMERISATION CATALYSTS | University Court of The University of St Andrews (GB) | 2016-08-17 | — | — | EP | disclosed |
| US-9233994-B2 | Ruthenium complexes for use in olefin metathesis | UNIVERSITY COURT OF THE UNIVERSITY OF ST. ANDREWS (GB) | 2016-01-12 | — | — | US | disclosed |
| US-20140228563-A1 | RUTHENIUM POLYMERISATION CATALYSTS | UNIVERSITY COURT OF THE UNIVERSITY OF ST. ANDREWS (GB) | 2014-08-14 | — | — | US | disclosed |
| US-20130165649-A1 | RUTHENIUM COMPLEXES FOR USE IN OLEFIN METATHESIS | UNIVERSITY COURT OF THE UNIVERSITY OF ST. ANDREWS (GB) | 2013-06-27 | — | — | US | disclosed |
| WO-2013045876-A1 | RUTHENIUM POLYMERISATION CATALYSTS | UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2013-04-04 | — | — | WO | disclosed |
| EP-2550284-A1 | RUTHENIUM COMPLEXES FOR USE IN OLEFIN METATHESIS | University Court Of The University Of St Andrews (GB) | 2013-01-30 | — | — | EP | disclosed |
| CN-102884070-A | ruthenium complexes for olefin metathesis | UNIV ST ANDREWS | 2013-01-16 | — | — | CN | disclosed |
| WO-2011117571-A1 | RUTHENIUM COMPLEXES FOR USE IN OLEFIN METATHESIS | UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2011-09-29 | — | — | WO | disclosed |
| EP-2044095-A1 | NEW RUTHENIUM COMPLEXES AS CATALYSTS FOR METAHESIS REACTIONS | F. Hoffmann-Roche AG (CH) | 2009-04-08 | — | — | EP | disclosed |
| WO-2008000644-A1 | NEW RUTHENIUM COMPLEXES AS CATALYSTS FOR METAHESIS REACTIONS | F. HOFFMANN-LA ROCHE AG (CH) | 2008-01-03 | — | — | WO | disclosed |
| EP-1037897-A1 | HIGHLY ACTIVE CATIONIC RUTHENIUM AND OSMIUM COMPLEXES FOR OLEFIN METATHESIS REACTIONS | Studiengesellschaft Kohle mbH (DE) | 2000-09-27 | — | — | EP | disclosed |
| WO-1999028330-A1 | HIGHLY ACTIVE CATIONIC RUTHENIUM AND OSMIUM COMPLEXES FOR OLEFIN METATHESIS REACTIONS | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 1999-06-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180065914-A1 | RUTHENIUM POLYMERISATION CATALYSTS | RRP12, PCBP1, PARG | PDIA6 685/4885ALDH1A1 4132/4885CA2 4278/4885 |
| US-20130165649-A1 | RUTHENIUM COMPLEXES FOR USE IN OLEFIN METATHESIS | OSBP, CYCS, OSBPL3 | PDIA6 1500/4885ALDH1A1 4330/4885CA2 3705/4885 |
| US-20140228563-A1 | RUTHENIUM POLYMERISATION CATALYSTS | RRP12, PCBP1, PARG | PDIA6 685/4885ALDH1A1 4132/4885CA2 4278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.